Terms: = Bone cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Diagnosis
45 results:
1. [Adenocarcinoma with Aplastic Anemia as an Immune-related Adverse Event Caused by Pembrolizumab: Report of a Case].
Hashimoto S; Haga N; Morimoto M; Doi Y
Kyobu Geka; 2024 Mar; 77(3):235-238. PubMed ID: 38465499
[TBL] [Abstract] [Full Text] [Related]
2. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
3. Imaging diagnosis and efficacy monitoring by [
He H; Qi X; Fu H; Xu J; Zheng Q; Chen L; Zhang Y; Hua H; Xu W; Xu Z; Chen X; You Q; Lin J; Huang G; Mao Y; Yu C
Theranostics; 2024; 14(1):392-405. PubMed ID: 38164149
[No Abstract] [Full Text] [Related]
4. Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus.
Hilder R; Tsai K; Quandt Z; Isaacs D; Drakaki A; Xing Y; In GK; Angell TE; Lechner MG
Front Endocrinol (Lausanne); 2023; 14():1242830. PubMed ID: 38027216
[TBL] [Abstract] [Full Text] [Related]
5. Neoadjuvant PD-1/pd-l1 axis blockade for patients with head and neck squamous cell carcinoma.
Huang S; Xiong C; Tan K
Am J Otolaryngol; 2023; 44(6):103985. PubMed ID: 37442083
[TBL] [Abstract] [Full Text] [Related]
6. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
Wang H; Li J; Li X
Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
[TBL] [Abstract] [Full Text] [Related]
7. Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.
Dalens L; Lecuelle J; Favier L; Fraisse C; Lagrange A; Kaderbhai C; Boidot R; Chevrier S; Mananet H; Derangère V; Truntzer C; Ghiringhelli F
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108755
[TBL] [Abstract] [Full Text] [Related]
8. Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow.
Nahas GR; Sherman LS; Sinha G; El Far MH; Petryna A; Munoz SM; Silverio KA; Shaker M; Neopane P; Mariotti V; Rameshwar P
Aging (Albany NY); 2023 Mar; 15(9):3230-3248. PubMed ID: 36996499
[TBL] [Abstract] [Full Text] [Related]
9. Metastasis of breast cancer to bones alters the tumor immune microenvironment.
Chao X; Zhang Y; Zheng C; Huang Q; Lu J; Pulver EM; Houthuijzen J; Hutten S; Luo R; He J; Sun P
Eur J Med Res; 2023 Mar; 28(1):119. PubMed ID: 36915210
[TBL] [Abstract] [Full Text] [Related]
10. Determination of diagnostic and predictive parameters for vertical mandibular invasion in patients with lower gingival squamous cell carcinoma: A retrospective study.
Shimizu T; Kim M; Palangka CRAP; Seki-Soda M; Ogawa M; Takayama Y; Yokoo S
Medicine (Baltimore); 2022 Dec; 101(49):e32206. PubMed ID: 36626519
[TBL] [Abstract] [Full Text] [Related]
11. Circulating Exosomal pd-l1 at Initial diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma.
Wang J; Guo W; Wang X; Tang X; Sun X; Ren T
Clin Cancer Res; 2023 Feb; 29(3):659-666. PubMed ID: 36374561
[TBL] [Abstract] [Full Text] [Related]
12. Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report.
Li WL; Zhang Y; Zhang XL; Du YY; Hu WQ; Zhao J
Hum Vaccin Immunother; 2022 Nov; 18(6):2121109. PubMed ID: 36166751
[TBL] [Abstract] [Full Text] [Related]
13. Simultaneous detection of cancerous exosomal miRNA-21 and pd-l1 with a sensitive dual-cycling nanoprobe.
Qin X; Xiang Y; Li N; Wei B; Chen Y; Fang D; Fang M; Li Q; Liu J; Tang Y; Li X; Yang F
Biosens Bioelectron; 2022 Nov; 216():114636. PubMed ID: 35986985
[TBL] [Abstract] [Full Text] [Related]
14. Response to treatment with an ALK-TKI in a patient with advanced lung adenocarcinoma with concurrent ALK fusion and high pd-l1 expression: A case report.
Zhang Y; Fang H; Hong J; Wang X; Wang H; Pan G
Medicine (Baltimore); 2022 Aug; 101(33):e30094. PubMed ID: 35984185
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases.
Qi P; Sun Y; Liu X; Wu S; Wo Y; Xu Q; Wang Q; Hu X; Zhou X
Cancer Med; 2023 Jan; 12(2):1177-1188. PubMed ID: 35822433
[TBL] [Abstract] [Full Text] [Related]
16. Vulvar cancer during pregnancy and/or breastfeeding: a report of five cases from a single center study at the University Hospital of Düsseldorf.
Winarno AS; Fehm TN; Hampl M
BMC Pregnancy Childbirth; 2022 Mar; 22(1):207. PubMed ID: 35291960
[TBL] [Abstract] [Full Text] [Related]
17. Cytoreductive Nephrectomy After Combination of Nivolumab Plus Ipilimumab for Mucinous Tubular and Spindle Cell Carcinoma of the Kidney With bone Metastases: A Case Report.
Furubayashi N; Taguchi K; Negishi T; Miura A; Sato Y; Miyoshi M; Nakamura M
In Vivo; 2022; 36(1):510-521. PubMed ID: 34972756
[TBL] [Abstract] [Full Text] [Related]
18. Primary histiocytic sarcoma of the clivus with focal extension into central nervous system and neurologic manifestations: First description at an unusual site with an overwhelming and rapid progression.
Perez I; Gokden M; Day JD; Yaziji H; Pina-Oviedo S
Clin Neuropathol; 2022; 41(2):74-82. PubMed ID: 34958302
[TBL] [Abstract] [Full Text] [Related]
19. A pd-l1 Negative Advanced Gastric cancer Patient With a Long Response to PD-1 Blockade After Failure of Systematic Treatment: A Case Report.
Zhang F; Zhang J; Zhao L; Zhai M; Zhang T; Yu D
Front Immunol; 2021; 12():759250. PubMed ID: 34950137
[TBL] [Abstract] [Full Text] [Related]
20. Response to toripalimab combined with radiotherapy in advanced non-small cell lung cancer-not otherwise specified: A case report.
Jin Y; Xiao W; Wang X; Cui Y; Li B; Liu X
Medicine (Baltimore); 2021 Oct; 100(42):e27581. PubMed ID: 34678907
[TBL] [Abstract] [Full Text] [Related]
[Next]
